Shares of vaccine makers Pfizer, GSK and Moderna dropped Wednesday as advisers to the Centers for Disease Control and Prevention shifted their recommendations for who should be vaccinated against respiratory syncytial virus.
Source link
Shares of vaccine makers Pfizer, GSK and Moderna dropped Wednesday as advisers to the Centers for Disease Control and Prevention shifted their recommendations for who should be vaccinated against respiratory syncytial virus.
Source link
